BioActor’s Research Director Sam Possemiers Introduces Cordiart® at MIS 2014: 21-22 May, Quimper- France

Maastricht, The Netherlands, March 3rd, 2014

Press release
Cordiart® clinically shows high bioavailability and improvements in endothelial function proving to be a great rutinoside formulation for cardiovascular health. The results of the clinical trial will be discussed in more detail in the Molécules & Ingrédients Santé (MIS) by BioActor’s research director Dr. Sam Possemiers.

Cordiart® in the spotlight at Molécules & Ingrédients Santé

For the 5th time, Molécules & Ingrédients Santé (MIS) will gather during 2 days industrial scientists, university researchers as well as experts to focus on last advances and future prospects in terms of new active ingredients, clinical tests and legislation.

BioActor’s research director Dr. Sam Possemiers will give a lecture on BioActor’s innovative cardiovascular ingredient Cordiart®. Cordiart®, a specific rutinoside formulation for cardiovascular health, has shown strong clinical data on the improvement of endothelial function. Cordiart® stimulates the eNOS-enzyme which plays a pivotal role in the synthesis of Nitric Oxide, one of the most important regulators of vascular elasticity. Parties have completed a pharmacokinetics study showing the high bioavailability of Cordiart®.

MIS 2014 will take place in Quimper, capital city of Cornouaille with a high industrial, R&D and training potential in the fields of nutrition and marine ingredients. The health products field still represents a strong profitable industry with a US $11 billion global market and a 5% annual growth. In the same time, dietary supplements turnover is now exceeding US $50 billion in spite of recent regulatory limitations. In this context and because of stronger requirements of consumers regarding efficacy of ingredients, innovation remains the keystone of this high value-added economy.

About BioActor

BioActor, based in Maastricht, Netherlands, is a product development company that has developed a range of proprietary bioactive ingredients for the nutrition & healthcare industry. The company focuses on the development of innovative activities that address active living and healthy aging. The goal is to provide the nutrition & healthcare industry with science-based innovations that confer a real health benefit to the consumer.

Feel free to contact us via info@bioactor.com for more information on the possibilities Cordiart® has to offer.
Further information can be found on: www.Cordiart.com